Stock Details
BDX is Becton, Dickinson and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 248.08$. Average daily volumn in 3 months 1.43M. Market cap 71.58B



Stock symbol : BDX. Exchange : NYSE. Currency : USD
Lastest price : 251.82$. Total volume : 1.23M. Market state PRE
Click reload if you want to check the lastest price on market!!!

Becton, Dickinson and Company (BDX)
Last Price
251.82$
Change
2.68
Volume
1.23M

Previous Close249.14
Open249.29
Day Range248.13-253.38
Bid235.00 x 900
Ask268.00 x 1k
Volume1.23M
Average Volume1.43M
Market Cap71.58B
Beta0.58
52 Week Range215.90-277.29
Trailing P/E46.81
Foward P/E18.82
Dividend (Yield %)1.45%
Ex-Dividend Date2023-03-09



Financial Details


According to Becton, Dickinson and Company's financial reports the company's revenue in 2022 were 18.87B an decrease(-5.26%) over the years 2021 revenue that were of 19.13B. In 2022 the company's total earnings were 1.78B while total earnings in 2021 were 2.09B(-50%).


Loading ...



Organization

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors an... d extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Market Cap:
71.58B
Revenue:
18.87B
Total Assets:
52.93B
Total Cash:
1.01B



News about "Becton, Dickinson and Company"

becton-dickinson-co-stock-outperforms-market-on-strong-trading-day-image

Becton Dickinson & Co. stock outperforms market on strong trading day

Source from : MarketWatch - 5 days ago

Shares of Becton Dickinson & Co. inched 0.42% higher to $246.78 Wednesday, on what proved to be an all-around mixed trading session for the stock ...See details»


Becton Dickinson and Co

Source from : Reuters - 28 days ago

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and ...See details»


The Price Is Right For Becton, Dickinson and Company (NYSE:BDX)

Source from : Yahoo - 1 month ago

Becton, Dickinson and Company's (NYSE:BDX) price-to-earnings (or "P/E") ratio of 45.7x might make it look like a strong sell right now compared to the market in the United States, where around ...See details»


Becton, Dickinson and Company's (NYSE:BDX) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Source from : Yahoo - 1 month ago

Becton Dickinson's (NYSE:BDX) stock is up by a considerable 8.8% over the past month. We wonder if and what role the company's financials play in that price change as a company's long-term ...See details»


Becton, Dickinson and Company Common Stock (BDX)

Source from : Nasdaq - 1 month ago

Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common ...See details»


Becton, Dickinson and Company

Source from : Fortune - 3 years ago

© 2022 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»


Do Its Financials Have Any Role To Play In Driving Becton, Dickinson and Company's (NYSE:BDX) Stock Up Recently?

Source from : Yahoo News - 19 days ago

Becton Dickinson's (NYSE:BDX) stock is up by a considerable 13% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term ...See details»


What 6 Analyst Ratings Have To Say About Becton, Dickinson

Source from : Benzinga.com - 23 days ago

In the last 3 months, 6 analysts have offered 12-month price targets for Becton, Dickinson. The company has an average price target of $270.33 with a high of $290.00 and a low of $245.00.See details»


Becton Dickinson Reaches New 52-Week High (BDX)

Source from : TheStreet.com - 10 days ago

Shares are up 4.6% year to date as of the close of trading on Monday. Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument ...See details»


Becton, Dickinson And Co. Raises FY22 Outlook Above Market View

Source from : Finanznachrichten - 7 days ago

WASHINGTON (dpa-AFX) - While announcing weak first quarter results, medical technology company Becton, Dickinson and Co. (BDX) raised its fiscal 2022 adjusted earnings per share and revenue guidance.See details»


Becton, Dickinson And Co. Recalls Intraosseous Products

Source from : Finanznachrichten - 6 days ago

WASHINGTON (dpa-AFX) - Medical technology company Becton, Dickinson and Company (BDX) on Wednesday announced a voluntary recall on the BD Intraosseous Needle Set Kits, BD Intraosseous Manual ...See details»


Why Becton Dickinson (BDX) Could Beat Earnings Estimates Again

Source from : YAHOO!Finance - 6 days ago

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.See details»


Becton Dickinson and Co

Source from : Newsweek - 21 days ago

Becton, Dickinson and Company (BD) is an American medical technology company that manufactures and sells medical devices, instrument systems, and reagents. Founded in 1897 and headquartered in ...See details»


Becton, Dickinson and Company Common Stock (BDX)

Source from : Nasdaq - 2 years ago

Dividend history information is presently unavailable for this company. This could indicate that the company has never provided a dividend or that a dividend is pending. Nasdaq Data provided by ...See details»